Avalyn Pharma CEO shares personal moment as company prepares for Nasdaq IPO

Avalyn Pharma and Generate Biomedicines executives talked about the long hours and challenges of preparing their companies for an initial public offering.

Avalyn CEO Lyn Baranowski highlighted a memorable moment at the Nasdaq bell ceremony, where a Morgan Stanley employee wore his late grandfather’s watch, a reminder of the idiopathic pulmonary fibrosis patients the company aims to help. Both Baranowski and the employee became emotional.

The interview underscored that the IPO process is more than financial paperwork; it is driven by personal commitment to the diseases the firms target, making the milestone feel human as well as business-related.